Immune Cell Populations in the Endometrium

NCT ID: NCT06826365

Last Updated: 2025-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Specialized immunological studies in the diagnostics of idiopathic infertility and recurrent miscarriages have limited applicability, as the role of the immune system in these conditions is not thoroughly understood. In ovulatory cycles, changes occur in the populations of uterine lymphocytes, which may influence the receptivity of the endometrium and the implantation of the embryo. Particularly notable are the changes in natural killer (NK) cells, which reach their peak during the luteal phase and regulate the invasion of the trophoblast. The dominant NK cells exhibit a CD56bright phenotype and differ in cytokine profiles from peripheral blood cells. Cyclical changes also affect macrophages and T lymphocytes; however, it is unclear whether their proportions differ in women with reduced fertility. There is a need to investigate how the composition of lymphocytes in blood influences the populations in the endometrium. The aim of this study is to analyze the correlation between peripheral and endometrial lymphocytes in women with idiopathic infertility and recurrent miscarriages, compared to fertile women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A cross-sectional study will be conducted among women aged 18-45 years undergoing aspiration biopsy as part of the diagnosis of: i) idiopathic infertility, ii) recurrent miscarriages, iii) other conditions requiring histopathological examination of the endometrium (control).

A 2 ml endometrial biopsy will be collected using the NEXODIS suction cannula on day 20-22 of the cycle, after confirmation of a negative result of B-human chorionic gonadotropin in the blood, and divided into 2 parts: 1 ml will be secured and sent for cytometric examination. At the same time, a peripheral blood sample (10 ml) will be collected in accordance with the SU in-hospital procedure and sent for cytometric examination.

Labeled blood cells and isolated single endometrial cells will be analyzed by flow cytometry using the FACSCanto2 system (BD Biosciences, USA). Blood cells will be stained directly with a panel of antibodies, and endometrial samples will be crushed and filtered before staining to isolate single cells. Then, the stained cells will be washed, erythrocytes will be lysed and centrifuged. It is planned to use a panel of monoclonal antibodies conjugated with fluorochromes, recognising the following markers: CD45, CD56, CD16, CD3, CD64, CD206, CD163, CD80, CD86 and CD138. The study population will be characterised in terms of age, BMI, gynecological data (surgeries, course of the menstrual cycle, nature of bleeding, ultrasound data) and obstetric data (pregnancies, deliveries, miscarriages). Characteristics of the study population, results of cytometric, histopathological, immunohistochemical endometrial and blood cytometric tests and their mutual correlation will be analysed using standard statistical methods.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility, Female Recurrent Miscarriage Gynecologic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Infertility

Women aged 18-45 with idiopathic infertility/recurrent miscarriages

Percentage distribution of immune system cells in peripheral blood

Intervention Type DIAGNOSTIC_TEST

Assessment of the percentage distribution of the immune system cell population in peripheral blood by flow cytometry

Percentage distribution of immune system cells in endometrium

Intervention Type DIAGNOSTIC_TEST

Assessment of the percentage distribution of the immune system cell population in endometrium by flow cytometry

Normal fertility

Women aged 18-45 with a history of normal pregnancy obtained by spontaneous fertilization

Percentage distribution of immune system cells in peripheral blood

Intervention Type DIAGNOSTIC_TEST

Assessment of the percentage distribution of the immune system cell population in peripheral blood by flow cytometry

Percentage distribution of immune system cells in endometrium

Intervention Type DIAGNOSTIC_TEST

Assessment of the percentage distribution of the immune system cell population in endometrium by flow cytometry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percentage distribution of immune system cells in peripheral blood

Assessment of the percentage distribution of the immune system cell population in peripheral blood by flow cytometry

Intervention Type DIAGNOSTIC_TEST

Percentage distribution of immune system cells in endometrium

Assessment of the percentage distribution of the immune system cell population in endometrium by flow cytometry

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-45 years
* idiopathic infertility
* at least 2 miscarriages
* other benign gynecological conditions subjected to endometrial sampling

Exclusion Criteria

* miscarriage within last 3 months
* abdominal/uterine surgery within last 3 months
* viral/bacterial infection within last 3 months
* antibiotic therapy within last 3 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jagiellonian University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Iwona Magdalena Gawron

PhD, MD, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kazimierz PityƄski, Prof., PhD

Role: STUDY_CHAIR

Jagiellonian University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Iwona Gawron, PhD, MD

Role: CONTACT

+48 124248570

Robert Jach, Prof., PhD

Role: CONTACT

+48 124248570

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1072.6120.301.2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Endometrial Biopsy in Infertile Patients
NCT00064935 COMPLETED PHASE3